Consumer Goods, Retail, Food & Beverages
Healthcare M&A
Pharmaceutical, Biotechnology and Medical Devices
Technology, Media & Telecom
Criminal Defense & Internal Investigations
Dispute settlement and Insurance Law
Dispute settlement & Insurance Law
Cross-border employment
Directors and governance
Employment law and remuneration policy
European & Competition Law
Antitrust, Concentrations & Dominance
Finance & Restructuring
Public sector funding
Government & Regulation
State advocate
Information, Communication and Technology (ICT) Law
Intellectual Property & Media
General administrative law
VAT and transfer tax
All Expertises
De Bestuurderspositie
Employee financial participation
Nieuw Pensioenstelsel
Partnerships in Tech
Working at Van Doorne
inloggen NLEN
Van Doorne assists with legal merger of Atrium and Orbis hospitals
Van Doorne
On 1 January 2015 the Atrium and Orbis hospitals legally merged. Van Doorne's Healthcare team advised the hospitals on the governance, employee participation and permits issues in this process.
The team also assisted with the financing and re-financing of the merger organisation and negotiations with the banks involved. On 31 December 2014 the merger was effected by the civil-law notary from Van Doorne.
The new Atrium-Orbis hospital wants to guarantee the quality of healthcare in the Parkstad and Westelijke Mijnstreek regions for the future by joining forces. They can now continue as a single healthcare organisation, with the goal of bringing healthcare in the Zuid-Limburg area to an even higher level.
The team from Van Doorne comprised Marg Janssen, Roel Botter, Robert Collenteur, Barbara Voermans, Dimitri van Hoewijk, Geert Drese, Anna Mars, Ivanka van Hassel, Jeske Remmers and Jan Willem Reesink.
Marg Janssen
Partner, Lawyer
Roel Botter
Roel has extensive experience in financial transactions. His experience includes acquisition finance, project finance, financial restructuring, structured finance, capital market transactions (debt and equity), asset-backed finance and regulatory matters.
Amsterdam: the pharma / life science hub in Europe!
Here's why top pharma and life sciences companies for which intellectual property and trade secrets are the core of their business are considering to move to the largest city of the Netherlands.
IT contract law: a Dutch approach
The freedom to contract what you like is quite broad in the Netherlands, especially in a B2B context. When moving your assets from the UK to the Netherlands, you may thus be inclined to just keep using the contract terms and conditions you are already familiar with. Nevertheless, the possible consequences of different legal systems could create challenges for your business. Also in the field of IT contracts.
Brexit and the EU regulatory framework for medicinal products
The European Medicines Agency (EMA) and the European Commission have published guidance to help pharmaceutical companies to prepare for the United Kingdom's withdrawal from the European Union. The guidance relates to both human and veterinary medicines.
Providing civil-law advice to patients is not the NZa's job
The Dutch Healthcare Authority (NZa) recently imposed a fine on an orthodontist. The NZa wanted to publish the decision to impose a fine on its website along with a news story. According to the court, however, the Government Information (Public Access) Act stood in the way of simply publishing the fining decision and news story. Care providers would be wise to be critical if the NZa wants to disclose information about them.
Amsterdam is the Dutch HealthTech start-up leader
On 21 April 2016 KPMG Innovative Startups and Volta Ventures presented their joint research in which they concluded that Amsterdam leads the race with regard to the quantity of digital health start-ups in the Netherlands. Amsterdam as HealthTech City. However, it is not a given fact that the solutions of these non-traditional market players will boost innovation in Dutch healthcare as we know it.
Private equity investments in Dutch healthcare at all time high
At Van Doorne London we aspire to keep you posted on relevant legal and market developments in the Netherlands. We recently noticed an interesting emerging trend of investments in Dutch healthcare. The number of acquisitions in the Dutch healthcare industry has never been as high as in 2015.
Million euro fine for Dutch association of general practitioners Days before the start of the new year, the Dutch competition authority (NMa) imposed a fine of €7.7m on the Dutch association of general practitioners (LHV). Almost every GP in the Netherlands is a member of the association. According to the NMa, the LHV had made illegal recommendations to its members relating to and restricting the establishment of new practices. The NMa also imposed personal fines of €50,000 and €25,000 on two LHV officials for their role in making the recommendations. To add insult to injury, the NMa fined the LHV for seal-breaking by a security guard during the investigation. The two LHV decisions (relating to establishment practices and the seal-breaking) are under appeal. The decision on the personal fines has not yet been published.
Our London office is equipped with a team of experienced partners with a broad range of expertise including those in the areas of insurance, corporate/M&A, finance, real estate and tax. The team is backed by more than 185 lawyers, civil-law notaries and tax lawyers in our Amsterdam offices.
More Van Doorne
About you and us